These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


563 related items for PubMed ID: 16263229

  • 21. Preparation and in vitro evaluation of liposomal/niosomal delivery systems for antifungal drug clotrimazole.
    Ning M, Gu Z, Pan H, Yu H, Xiao K.
    Indian J Exp Biol; 2005 Feb; 43(2):150-7. PubMed ID: 15782815
    [Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Fabrication of acetazolamide loaded leciplex for intraocular delivery: Optimization by 32 full factorial design, in vitro, ex vivo and in vivo pharmacodynamics.
    Bagul US, Khot SV, Ashtekar KS, Monde AA, Kolhe OH, Tagalpallewar AA, Kokare CR.
    Int J Pharm; 2024 Aug 15; 661():124391. PubMed ID: 38936444
    [Abstract] [Full Text] [Related]

  • 24. Physicochemical properties and skin permeation of Span 60/Tween 60 niosomes of ellagic acid.
    Junyaprasert VB, Singhsa P, Suksiriworapong J, Chantasart D.
    Int J Pharm; 2012 Feb 28; 423(2):303-11. PubMed ID: 22155414
    [Abstract] [Full Text] [Related]

  • 25. Formulation and investigation of pilocarpine hydrochloride niosomal gels for the treatment of glaucoma: intraocular pressure measurement in white albino rabbits.
    Jain N, Verma A, Jain N.
    Drug Deliv; 2020 Dec 28; 27(1):888-899. PubMed ID: 32551978
    [Abstract] [Full Text] [Related]

  • 26. Proniosomes as drug carriers.
    Sankar V, Ruckmani K, Durga S, Jailani S.
    Pak J Pharm Sci; 2010 Jan 28; 23(1):103-7. PubMed ID: 20067875
    [Abstract] [Full Text] [Related]

  • 27. Acetazolamide encapsulated dendritic nano-architectures for effective glaucoma management in rabbits.
    Mishra V, Jain NK.
    Int J Pharm; 2014 Jan 30; 461(1-2):380-90. PubMed ID: 24291772
    [Abstract] [Full Text] [Related]

  • 28. In vitro study of polyoxyethylene alkyl ether niosomes for delivery of insulin.
    Pardakhty A, Varshosaz J, Rouholamini A.
    Int J Pharm; 2007 Jan 10; 328(2):130-41. PubMed ID: 16997517
    [Abstract] [Full Text] [Related]

  • 29. Preparation of acetazolamide composite microparticles by supercritical anti-solvent techniques.
    Duarte AR, Roy C, Vega-González A, Duarte CM, Subra-Paternault P.
    Int J Pharm; 2007 Mar 06; 332(1-2):132-9. PubMed ID: 17055198
    [Abstract] [Full Text] [Related]

  • 30. Polysaccharide coated niosomes for oral drug delivery: formulation and in vitro stability studies.
    Sihorkar V, Vyas SP.
    Pharmazie; 2000 Feb 06; 55(2):107-13. PubMed ID: 10723768
    [Abstract] [Full Text] [Related]

  • 31. Pharmacokinetic study of niosome encapsulated insulin.
    Khaksa G, D'Souza R, Lewis S, Udupa N.
    Indian J Exp Biol; 2000 Sep 06; 38(9):901-5. PubMed ID: 12561948
    [Abstract] [Full Text] [Related]

  • 32. Novel cubosome based system for ocular delivery of acetazolamide.
    Teba HE, Khalil IA, El Sorogy HM.
    Drug Deliv; 2021 Dec 06; 28(1):2177-2186. PubMed ID: 34662264
    [Abstract] [Full Text] [Related]

  • 33. Stability of luciferase plasmid entrapped in cationic bilayer vesicles.
    Manosroi A, Thathang K, Werner RG, Schubert R, Manosroi J.
    Int J Pharm; 2008 May 22; 356(1-2):291-9. PubMed ID: 18281170
    [Abstract] [Full Text] [Related]

  • 34. Preparation and characterization of niosomes containing rifampicin for lung targeting.
    Jain CP, Vyas SP.
    J Microencapsul; 1995 May 22; 12(4):401-7. PubMed ID: 8583314
    [Abstract] [Full Text] [Related]

  • 35. Proniosomes as a drug carrier for transdermal delivery of ketorolac.
    Alsarra IA, Bosela AA, Ahmed SM, Mahrous GM.
    Eur J Pharm Biopharm; 2005 Apr 22; 59(3):485-90. PubMed ID: 15760729
    [Abstract] [Full Text] [Related]

  • 36. Natamycin niosomes as a promising ocular nanosized delivery system with ketorolac tromethamine for dual effects for treatment of candida rabbit keratitis; in vitro/in vivo and histopathological studies.
    El-Nabarawi MA, Abd El Rehem RT, Teaima M, Abary M, El-Mofty HM, Khafagy MM, Lotfy NM, Salah M.
    Drug Dev Ind Pharm; 2019 Jun 22; 45(6):922-936. PubMed ID: 30744431
    [Abstract] [Full Text] [Related]

  • 37. Studies on nonionic surfactant bilayer vesicles of ciclopirox olamine.
    Shaikh KS, Chellampillai B, Pawar AP.
    Drug Dev Ind Pharm; 2010 Aug 22; 36(8):946-53. PubMed ID: 20196642
    [Abstract] [Full Text] [Related]

  • 38. Probing influence of methodological variation on active loading of acetazolamide into nanoliposomes: biophysical, in vitro, ex vivo, in vivo and rheological investigation.
    Pisal PB, Joshi MA, Padamwar MN, Patil SS, Pokharkar VB.
    Int J Pharm; 2014 Jan 30; 461(1-2):82-8. PubMed ID: 24291077
    [Abstract] [Full Text] [Related]

  • 39. Characteristics of niosomes prepared by supercritical carbon dioxide (scCO2) fluid.
    Manosroi A, Chutoprapat R, Abe M, Manosroi J.
    Int J Pharm; 2008 Mar 20; 352(1-2):248-55. PubMed ID: 18036754
    [Abstract] [Full Text] [Related]

  • 40. In vitro characterisation of Span 65 niosomal formulations containing proteins.
    Haj-Ahmad RR, Elkordy AA, Chaw CS.
    Curr Drug Deliv; 2015 Mar 20; 12(5):628-39. PubMed ID: 25963305
    [Abstract] [Full Text] [Related]


    Page: [Previous] [Next] [New Search]
    of 29.